Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Related Citations for PubMed (Select 21295450)

1.

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.

De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU.

Eur Psychiatry. 2011 Apr;26(3):144-58. doi: 10.1016/j.eurpsy.2010.09.011. Epub 2011 Feb 3. Review.

PMID:
21295450
2.

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.

Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C.

Eur Neuropsychopharmacol. 2011 Aug;21(8):621-45. doi: 10.1016/j.euroneuro.2010.07.002. Epub 2010 Aug 10. Review.

PMID:
20702068
3.
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
6.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
7.

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

Maayan L, Correll CU.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35. doi: 10.1089/cap.2011.0015. Epub 2011 Dec 13. Review.

PMID:
22166172
8.

Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.

Almandil NB, Liu Y, Murray ML, Besag FM, Aitchison KJ, Wong IC.

Paediatr Drugs. 2013 Apr;15(2):139-50. doi: 10.1007/s40272-013-0016-6. Review.

PMID:
23519708
9.

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.

Zuddas A, Zanni R, Usala T.

Eur Neuropsychopharmacol. 2011 Aug;21(8):600-20. doi: 10.1016/j.euroneuro.2011.04.001. Epub 2011 May 6. Review.

PMID:
21550212
10.

Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

Pringsheim T, Lam D, Ching H, Patten S.

Drug Saf. 2011 Aug 1;34(8):651-68. doi: 10.2165/11592020-000000000-00000. Review.

PMID:
21751826
11.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
12.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
13.

Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.

Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C.

J Clin Psychopharmacol. 2012 Jun;32(3):309-16. doi: 10.1097/JCP.0b013e3182549259. Review.

PMID:
22544019
14.

Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Masi G, Liboni F.

Drugs. 2011 Jan 22;71(2):179-208. doi: 10.2165/11585350-000000000-00000. Review.

PMID:
21275445
15.

Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials.

Jensen PS, Buitelaar J, Pandina GJ, Binder C, Haas M.

Eur Child Adolesc Psychiatry. 2007 Mar;16(2):104-20. Epub 2006 Oct 30. Review.

PMID:
17075688
16.

Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Stigler KA, Potenza MN, Posey DJ, McDougle CJ.

Paediatr Drugs. 2004;6(1):33-44. Review.

PMID:
14969568
17.
18.

Use of atypical antipsychotics in the treatment of autistic disorder.

Stachnik JM, Nunn-Thompson C.

Ann Pharmacother. 2007 Apr;41(4):626-34. Epub 2007 Mar 27. Review.

PMID:
17389666
19.

Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.

Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C.

Bipolar Disord. 2010 Mar;12(2):172-84. doi: 10.1111/j.1399-5618.2010.00797.x.

PMID:
20402710
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk